Serum high mobility group box-1 (HMGB1) is closely associated with the clinical and pathologic features of gastric cancer. - Wikidata - awgldk - TriplyDB

Serum high mobility group box-1 (HMGB1) is closely associated with the clinical and pathologic features of gastric cancer.

Serum high mobility group box-1 (HMGB1) is closely associated with the clinical and pathologic features of gastric cancer.

http://www.wikidata.org/entity/Q37222012

about

Circulating HMGB1 and RAGE as Clinical Biomarkers in Malignant and Autoimmune Diseases The Role of HMGB1 Signaling Pathway in the Development and Progression of Hepatocellular Carcinoma: A Review Damage-associated molecular patterns in cancer: a double-edged sword HMGB1 conveys immunosuppressive characteristics on regulatory and conventional T cells Plasma free amino acid profiling of five types of cancer patients and its application for early detection Alarmins: awaiting a clinical response High-mobility group box 1 and cancer.Antitumor immunity induced after α irradiation Prognostic value of HMGB1 overexpression in resectable gastric adenocarcinomas.Diagnostic significance of serum HMGB1 in colorectal carcinomas The "Excellence in Translational Medicine" and "Bedside-to-Bench" Awards 2008-09.Identification and characterization of the lamprey high-mobility group box 1 gene.HMGB1 in health and disease.High mobility group box-1 and its clinical value in breast cancer.Autophagy-mediated HMGB1 release promotes gastric cancer cell survival via RAGE activation of extracellular signal-regulated kinases 1/2.High-mobility group box 1 expression and lymph node metastasis in intrahepatic cholangiocarcinoma.Elevated HMGB1-related interleukin-6 is associated with dynamic responses of monocytes in patients with active pulmonary tuberculosis.Association of RAGE polymorphisms and cancer risk: a meta-analysis of 27 studies.Carbon-ion beams induce production of an immune mediator protein, high mobility group box 1, at levels comparable with X-ray irradiation Prognostic Significance of Tag SNP rs1045411 in HMGB1 of the Aggressive Gastric Cancer in a Chinese Population.Relationship between high-mobility group box 1 overexpression in ovarian cancer tissue and serum: a meta-analysis.Immunogenic tumor cell death induced by chemoradiotherapy: molecular mechanisms and a clinical translation.Double-positive expression of high-mobility group box 1 and vascular endothelial growth factor C indicates a poorer prognosis in gastric cancer patients Helicobacter pylori Activates HMGB1 Expression and Recruits RAGE into Lipid Rafts to Promote Inflammation in Gastric Epithelial Cells.Genetic predisposition of six well-defined polymorphisms in HMGB1/RAGE pathway to breast cancer in a large Han Chinese population HMGB1 level in cerebrospinal fluid as a complimentary biomarker for the diagnosis of tuberculous meningitis Dysregulation of signaling pathways associated with innate antibacterial immunity in patients with pancreatic cancer.HMGB1 in hormone-related cancer: a potential therapeutic target.Pivotal role of high-mobility group box 1 (HMGB1) signaling pathways in glioma development and progression.Combined targeting of high-mobility group box-1 and interleukin-8 to control micrometastasis potential in gastric cancer.HMGB1, IL-1α, IL-33 and S100 proteins: dual-function alarmins Targeting HMGB1 inhibits ovarian cancer growth and metastasis by lentivirus-mediated RNA interference.Effect of HMGB1 silencing on cell proliferation, invasion and apoptosis of MGC-803 gastric cancer cells.Gene expression disorders of innate antibacterial signaling pathway in pancreatic cancer patients: implications for leukocyte dysfunction and tumor progression Expression levels and clinical significance of hepsin and HMGB1 proteins in cervical carcinoma HMGB1: A Promising Therapeutic Target for Prostate Cancer.High-mobility group box-1 contributes tumor angiogenesis under interleukin-8 mediation during gastric cancer progression.A multicenter matched case-control analysis on seven polymorphisms from HMGB1 and RAGE genes in predicting hepatocellular carcinoma risk.Correlation of HMGB1 expression to progression and poor prognosis of adenocarcinoma and squamous cell/adenosquamous carcinoma of gallbladder.Predictive value of immunogenic cell death biomarkers HMGB1, sRAGE, and DNase in liver cancer patients receiving transarterial chemoembolization therapy.

P2860

Q26768480-DB407F22-9EDD-40DC-ABC6-9062736E1388 Q26782281-0414580C-8E27-4AB9-86AF-5C6BF8C93987 Q28067434-A055D86D-6A3E-482B-84F2-2A4B145B47E0 Q28117763-6F87CF05-1EC3-4C17-8B4F-0F9AD86F14E3 Q28740654-8B601539-BD60-4906-9B4B-DA415B100918 Q30523797-73E98F9F-AFCD-42A8-933D-237DA84869B2 Q33638306-7DFDB146-AB16-4838-85E8-25BFB03E4E48 Q33891246-BB034444-44BE-4859-96F7-6B301ADBF7E7 Q34019875-4872DDF4-93AB-4BC3-AA9D-E93515F21B2A Q34230026-8E7FE4D5-9B27-4D86-987B-88A495F3CC09 Q34243570-F65D33F1-3A55-443B-84B2-C0D0C5A635D5 Q34259728-6901678A-C9B5-46F8-8206-99FB98A467C7 Q34622835-7CAC9628-DE02-47C3-9085-EFEEAF9A49FB Q35101004-96ABAB87-345E-458C-B5CB-280E2CD0BFB5 Q35172545-26403A6F-B67C-443D-A232-8F5477FDEC00 Q35188596-0CBABF3C-5671-4576-9F3D-16E71A368877 Q35406168-C6806B80-D3FE-4702-A7C3-0D41945FD72D Q35545467-E2AEC4A4-13AA-4AE8-9915-BF466FBBC2D2 Q35591847-9CD3BBAD-D179-43C6-A954-8A4F96F701E8 Q35999764-2BB5B95D-79B3-46E0-887B-8CEE0C707254 Q36347619-7BAF0AEB-52B7-4353-BCC3-DAF2F31489CD Q36985164-39B0D844-AFAF-4DBA-AEC1-2118ADE5C3AD Q37071863-5BB047CB-F2B3-475C-9F0C-E2796D3C5EA5 Q37242901-FFA217FF-A267-4466-94CE-23DD6CEA0C7E Q37251612-0527038D-DBF8-4715-9D03-B6097C276ADB Q37334747-19199CB5-2BD4-49D3-B67A-D289F5AB18B1 Q37739809-DE286F6B-32B3-49C4-8BBF-B63A536A6454 Q38203471-FDD7BC05-B1D2-4B02-A1E6-D0675E93799B Q38855171-8BA51920-0BD1-4DC7-AAC4-EC88C11E9F66 Q38893404-23A5BE29-B534-4A42-B8E6-DFCA8B874028 Q38939435-E61D2922-74AC-43C7-8CCA-1802F54012D6 Q39396939-C3263484-296C-4106-9383-88F6D3D0B4A7 Q39467052-B740B235-17AE-42E7-8F7F-7962112A9B61 Q40923346-C245B0FA-22CB-4254-A332-58FA21EC9A20 Q40978463-FC30DD10-2807-41C7-9D0C-C46C59D7EE3B Q41136849-2CDB7816-EF22-4852-92CD-8FB9684A1BA6 Q41248552-1AA2B212-6B5B-484F-B122-B86264A8DB43 Q41472938-A28C9F0A-4550-4F3D-BDC3-0C8C563F3654 Q42068869-2EF4BA2A-7845-4CC4-B961-E2BF1C11EEBA Q44844478-B818B8AA-E491-43DA-B04A-B98D12C8AA3C

P2860

Serum high mobility group box-1 (HMGB1) is closely associated with the clinical and pathologic features of gastric cancer.

http://www.wikidata.org/entity/Q37222012

description

article científic

@ca

article scientifique

@fr

articolo scientifico

@it

artigo científico

@pt

bilimsel makale

@tr

scientific article published on 28 May 2009

@en

vedecký článok

@sk

vetenskaplig artikel

@sv

videnskabelig artikel

@da

vědecký článek

@cs

name

Serum high mobility group box- ...... ic features of gastric cancer.

@en

Serum high mobility group box-1

@nl

type

label

Serum high mobility group box- ...... ic features of gastric cancer.

@en

Serum high mobility group box-1

@nl

prefLabel

Serum high mobility group box- ...... ic features of gastric cancer.

@en

Serum high mobility group box-1

@nl

P1433

Q37222012-AEFDA306-C26C-4ABA-ABFD-69C64E351071

P1476

Q37222012-AC8E1B58-8042-4C57-A005-C97124173B73

P2093

Q37222012-1E842BBD-3AC1-4E10-81F0-5FD21C64C371

Q37222012-AD483D57-3F7C-427D-89CF-A87F1D040D1E

Q37222012-B278C812-0C9B-4CBE-A736-0F6B91D68529

Q37222012-B5C1B1E9-D93D-46E6-8EFA-4BBC878D79E9

Q37222012-B8B25024-72F9-4EAF-84CB-935F250140E2

Q37222012-B937E5FB-8275-4DAF-BAC8-0908EE2C2C60

Q37222012-DE29C146-AFFB-423E-9CAF-D52AFCB447A5

P2860

Q37222012-0796229E-F2CE-4E83-BE7A-53C82BCBC070

Q37222012-0DBBF66D-ADA8-4657-8BC3-E3BE58F9FBB5

Q37222012-1F4922D3-FE8A-44A7-A6D1-225154F7034D

Q37222012-1F54B5BE-405A-4D07-9E8D-479E2BB1596B

Q37222012-278CC329-EC34-46F4-9913-0ADD33CBF2EA

Q37222012-35A83AB2-BD98-4AE4-AF27-7DBBBEE8C836

Q37222012-4A8F0785-F45F-4088-A832-7864154104C6

Q37222012-74A14F96-3CF0-4554-8144-C7654916239C

Q37222012-77E16F8F-27C5-4331-9729-3E6DC484EC50

Q37222012-9446C86D-0390-48B5-992C-C065A98A7D85

P2888

Q37222012-3BFC8266-44B2-47B4-A889-55146105A4D4

P304

Q37222012-CD367B91-9255-4CC0-A1D8-50E422A8911D

P31

Q37222012-532EB266-2A4A-4FFF-8177-83457E595166

P356

Q37222012-C29952DD-0890-43DD-B9C5-9EA61BEC46AE

P478

Q37222012-5D42760B-2B3F-44EF-85B5-897BB48B559E

P577

Q37222012-D5D12F2F-3F9E-4152-A005-16BAA8E5F6B2

P5875

Q37222012-81A5EDFC-3CCE-4AB4-9B83-0D3AACB7061B

P6179

Q37222012-38ACBD7E-7AC3-4725-AF4F-655685D2C4F9

P698

Q37222012-5C4A85A4-4933-4727-AB8F-8DBD4317BAB5

P932

Q37222012-E8A6CF1E-7C67-41B1-9D41-F181E17D6F9C

P356

P1433

Journal of Translational Medicine

P1476

Serum high mobility group box- ...... ic features of gastric cancer.

@en

P2093

David Stroncek

http://www.w3.org/2001/XMLSchema#string

Duck Jin Hong

http://www.w3.org/2001/XMLSchema#string

Heejung Kim

http://www.w3.org/2001/XMLSchema#string

Hye Won Chung

http://www.w3.org/2001/XMLSchema#string

Jae Bock Chung

http://www.w3.org/2001/XMLSchema#string

Jong-Baeck Lim

http://www.w3.org/2001/XMLSchema#string

Sang-Guk Lee

http://www.w3.org/2001/XMLSchema#string

P2860

HMGB1 mediates endogenous TLR2 activation and brain tumor regression

Release of chromatin protein HMGB1 by necrotic cells triggers inflammation

HMG-1 as a late mediator of endotoxin lethality in mice

High-mobility group box 1 protein (HMGB1): nuclear weapon in the immune arsenal

Masquerader: high mobility group box-1 and cancer

Expression of high-mobility group-1 mRNA in human gastrointestinal adenocarcinoma and corresponding non-cancerous mucosa

Extracellular HMGB1, a signal of tissue damage, induces mesoangioblast migration and proliferation

Toll-like receptor 4-dependent contribution of the immune system to anticancer chemotherapy and radiotherapy

Down-regulation of the receptor for advanced glycation end-products (RAGE) supports non-small cell lung carcinoma.

The epidemiology of gastric cancer.

P2888

P304

38

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1186/1479-5876-7-38

http://www.w3.org/2001/XMLSchema#string

P478

7

http://www.w3.org/2001/XMLSchema#string

P577

2009-05-28T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

26247908

http://www.w3.org/2001/XMLSchema#string

P6179

1051265448

http://www.w3.org/2001/XMLSchema#string

P698

19476625

http://www.w3.org/2001/XMLSchema#string

P932

2694170

http://www.w3.org/2001/XMLSchema#string